Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
出版年份 2018 全文链接
标题
Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer
作者
关键词
Bladder cancer, 5-Hydroxymethylcytosine, Vitamin C, TET
出版物
Clinical Epigenetics
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-07-13
DOI
10.1186/s13148-018-0527-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
- (2017) J. Alfred Witjes et al. EUROPEAN UROLOGY
- Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells
- (2017) N Shenoy et al. Blood Cancer Journal
- L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells
- (2016) Soo-A. Jung et al. FREE RADICAL BIOLOGY AND MEDICINE
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Tumour hypoxia causes DNA hypermethylation by reducing TET activity
- (2016) Bernard Thienpont et al. NATURE
- Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to naïve pluripotency by complementary mechanisms
- (2016) Timothy Alexander Hore et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vitamin C increases viral mimicry induced by 5-aza-2′-deoxycytidine
- (2016) Minmin Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies
- (2016) Enrico Munari et al. PLoS One
- Ascorbic acid and ascorbate-2-phosphate decrease HIF activity and malignant properties of human melanoma cells
- (2015) Sarah L. Miles et al. BMC CANCER
- Stable 5-Hydroxymethylcytosine (5hmC) Acquisition Marks Gene Activation During Chondrogenic Differentiation
- (2015) Sarah EB Taylor et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
- (2015) J. Yun et al. SCIENCE
- Vitamin C Facilitates Dopamine Neuron Differentiation in Fetal Midbrain Through TET1- and JMJD3-Dependent Epigenetic Control Manner
- (2015) Xi-Biao He et al. STEM CELLS
- Epigenetic reprogramming of melanoma cells by vitamin C treatment
- (2015) Christopher B Gustafson et al. Clinical Epigenetics
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
- (2014) Y. Ma et al. Science Translational Medicine
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer
- (2013) Christopher M. Stephenson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TET enzymatic oxidation of 5-methylcytosine, 5-hydroxymethylcytosine and 5-formylcytosine
- (2013) Jean Cadet et al. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
- Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
- (2013) Kathryn Blaschke et al. NATURE
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
- (2012) Christine Guo Lian et al. CELL
- Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization
- (2012) Iouri Chepelev et al. CELL RESEARCH
- Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
- (2012) H Yang et al. ONCOGENE
- TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases
- (2012) Chih-Hung Hsu et al. Cell Reports
- 5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
- (2011) S.-G. Jin et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
- (2009) M. Tahiliani et al. SCIENCE
- Expanding chemical biology of 2-oxoglutarate oxygenases
- (2008) Christoph Loenarz et al. Nature Chemical Biology
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
- (2008) Q. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started